Stay updated on Preventing GvHD in Allo ApoGraft SCT - Clinical Trial
Sign up to get notified when there's something new on the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page.

Latest updates to the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added to the history, and the older funding notice and revision v3.4.1 were removed.SummaryDifference0.8%

- Check21 days agoChange DetectedA site-wide notice regarding government funding was added and the revision history shows a new revision v3.4.1, with the previous v3.4.0 entry removed.SummaryDifference0.8%

- Check28 days agoChange DetectedThe record history page now shows additions in green and deletions in red, adds a Show glossary option, and updates the revision label to v3.4.0 while removing the prior No FEAR Act data note. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check42 days agoChange DetectedThe history adds revision v3.3.4, replacing v3.3.3. No study details or outcomes appear to be affected.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.3.3 was added to the Record History, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check85 days agoChange DetectedA new revision entry v3.3.2 was added to the record history, and revision v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Preventing GvHD in Allo ApoGraft SCT - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page.